Publications of Bozidar Novak
All genres
Journal Article (8)
2023
Journal Article
282, 104925 (2023)
Chronic fluoxetine treatment in socially-isolated rats modulates the prefrontal cortex synaptoproteome. JOURNAL OF PROTEOMICS 2022
Journal Article
501, pp. 52 - 71 (2022)
Chronic Fluoxetine Treatment of Socially Isolated Rats Modulates Prefrontal Cortex Proteome. NEUROSCIENCE
Journal Article
110 (14), pp. 2283 - 2298.e9 (2022)
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2. NEURON 2021
Journal Article
51, pp. 20 - 32 (2021)
MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
15, 100401 (2021)
Analysis of the cerebellar molecular stress response led to first evidence of a role for FKBP51 in brain FKBP52 expression in mice and humans. NEUROBIOLOGY OF STRESS
Journal Article
129, 105242 (2021)
Oxytocin receptor is a potential biomarker of the hyporesponsive HPA axis subtype of PTSD and might be modulated by HPA axis reactivity traits in humans and mice. PSYCHONEUROENDOCRINOLOGY 2020
Journal Article
129, pp. 8 - 14 (2020)
Paroxetine binding and activation of phosphofructokinase implicates energy metabolism in antidepressant mode of action. JOURNAL OF PSYCHIATRIC RESEARCH 2019
Journal Article
15 (9), e1008358 (2019)
Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior. PLoS Genetics Meeting Abstract (1)
2022
Meeting Abstract
63, p. E101 - E101. (2022)
GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,